Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE

Biogen Says Panel Backs Genentech Partnership

By Pharmaceutical Processing | June 17, 2009

CAMBRIDGE, Mass. (AP) — Biogen Idec Inc. said Tuesday an arbitration panel affirmed its right to participate in strategic decisions in a partnership with Genentech, which includes the cancer drug Rituxan and other drug candidates. The panel ruled that a committee of three Biogen employees and three Genentech employees must unanimously approve all plans to develop drug candidates for each possible indication, Biogen said. The companies have collaborated since 1995, but when Biogen Inc. and IDEC Pharmaceuticals combined in 2003, Genentech said the terms of the partnership were no longer valid. Biogen Idec co-markets Rituxan in the U.S. with Genentech, which is being bought by Roche Holding AG. The drug is approved to treat B-cell non-Hodgkin lymphoma and rheumatoid arthritis. Biogen said the ruling means South San Francisco-based Genentech can’t proceed with developing 2H7v16 for neuromyelitis optica or relapsing-remitting multiple sclerosis, or 2H7v114 for cancer. However, Genentech can continue trials of 2H7 drugs for rheumatoid arthritis and lupus.

Related Articles Read More >

This is the logo of Hikma.
Hikma to spend another $1B on US manufacturing, R&D
Sandoz Logo 2025
Sandoz breaks ground on biosimilar plant in Slovenia
Nymi Logo_2022 (1)
Nymi, Caliber partner on passwordless authentication for pharma manufacturing
Building a resilient pharma supply chain
“ppw
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news, technologies, and developments in Pharmaceutical Processing.

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Pharmaceutical Processing World
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Drug Discovery & Development
  • DeviceTalks
  • MassDevice
  • Medical Design & Outsourcing
  • MEDICAL TUBING + EXTRUSION
  • Medical Design Sourcing
  • Medtech100 Index
  • R&D 100 Awards

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Equipment and Materials
  • Contract Manufacturing
  • Resources
    • Voices
  • Advertise
  • SUBSCRIBE